Gene Therapy for Liver Cancers: Current Status from Basic to Clinics

Overview

Journal Cancers (Basel)

Publisher MDPI

Specialty Oncology

Date 2019 Nov 27

PMID 31769427

Citations 12

Authors

Kenya Kamimura

Takeshi Yokoo

Hiroyuki Abe

Shuji Terai

Affiliations

Soon will be listed here.

Abstract

The liver is a key organ for metabolism, protein synthesis, detoxification, and endocrine function, and among liver diseases, including hepatitis, cirrhosis, malignant tumors, and congenital disease, liver cancer is one of the leading causes of cancer-related deaths worldwide. Conventional therapeutic options such as embolization and chemotherapy are not effective against advanced-stage liver cancer; therefore, continuous efforts focus on the development of novel therapeutic options, including molecular targeted agents and gene therapy. In this review, we will summarize the progress toward the development of gene therapies for liver cancer, with an emphasis on recent clinical trials and preclinical studies.

Citing Articles

A Review on the Extraction, Structural Analysis, and Antitumor Mechanisms of Polysaccharides.

Liang H, Ma Y, Zhao Y, Qayyum N, He F, Tian J Foods. 2025; 14(4).

PMID: 40002150 PMC: 11854207. DOI: 10.3390/foods14040707.

Intelligent Hydrogel-Assisted Hepatocellular Carcinoma Therapy.

Tang Z, Deng L, Zhang J, Jiang T, Xiang H, Chen Y Research (Wash D C). 2024; 7:0477.

PMID: 39691767 PMC: 11651419. DOI: 10.34133/research.0477.

Targeting Hypoxia-Inducible Factor-1α for the Management of Hepatocellular Carcinoma.

Huynh K, Rao S, Roth B, Bryan T, Fernando D, Dayyani F Cancers (Basel). 2023; 15(10).

PMID: 37345074 PMC: 10216171. DOI: 10.3390/cancers15102738.

Hybrid Polydimethylsiloxane (PDMS) Incorporated Thermogelling System for Effective Liver Cancer Treatment.

Ma P, Jiang L, Luo X, Chen J, Wang Q, Chen Y Pharmaceutics. 2022; 14(12).

PMID: 36559118 PMC: 9781567. DOI: 10.3390/pharmaceutics14122623.

Zwitterionic Modification of Polyethyleneimine for Efficient siRNA Delivery.

Liu F, Su H, Li M, Xie W, Yan Y, Shuai Q Int J Mol Sci. 2022; 23(9).

PMID: 35563405 PMC: 9100541. DOI: 10.3390/ijms23095014.

References

Sobrevals L, Enguita M, Rodriguez C, Gonzalez-Rojas J, Alzaguren P, Razquin N . AAV vectors transduce hepatocytes in vivo as efficiently in cirrhotic as in healthy rat livers. Gene Ther. 2011; 19(4):411-7. DOI: 10.1038/gt.2011.119. View

Hou J, Zhang H, Sun B, Karin M . The immunobiology of hepatocellular carcinoma in humans and mice: Basic concepts and therapeutic implications. J Hepatol. 2019; 72(1):167-182. DOI: 10.1016/j.jhep.2019.08.014. View

Wang P, Qin W, Liu T, Jiang D, Cui L, Liu X . PiggyBac-engineered T cells expressing a glypican-3-specific chimeric antigen receptor show potent activities against hepatocellular carcinoma. Immunobiology. 2019; 225(1):151850. DOI: 10.1016/j.imbio.2019.09.009. View

Kanwal F, Singal A . Surveillance for Hepatocellular Carcinoma: Current Best Practice and Future Direction. Gastroenterology. 2019; 157(1):54-64. PMC: 6636644. DOI: 10.1053/j.gastro.2019.02.049. View

Kamimura K, Liu D . Physical approaches for nucleic acid delivery to liver. AAPS J. 2008; 10(4):589-95. PMC: 2628207. DOI: 10.1208/s12248-008-9067-y. View

Harrington K, Freeman D, Kelly B, Harper J, Soria J . Optimizing oncolytic virotherapy in cancer treatment. Nat Rev Drug Discov. 2019; 18(9):689-706. DOI: 10.1038/s41573-019-0029-0. View

van der Laan L, Wang Y, Tilanus H, Janssen H, Pan Q . AAV-mediated gene therapy for liver diseases: the prime candidate for clinical application?. Expert Opin Biol Ther. 2011; 11(3):315-27. DOI: 10.1517/14712598.2011.548799. View

Penuelas I, Mazzolini G, Boan J, Sangro B, Marti-Climent J, Ruiz M . Positron emission tomography imaging of adenoviral-mediated transgene expression in liver cancer patients. Gastroenterology. 2005; 128(7):1787-95. DOI: 10.1053/j.gastro.2005.03.024. View

Fu Y, Liu S, Zeng S, Shen H . From bench to bed: the tumor immune microenvironment and current immunotherapeutic strategies for hepatocellular carcinoma. J Exp Clin Cancer Res. 2019; 38(1):396. PMC: 6734524. DOI: 10.1186/s13046-019-1396-4. View

10.

ATCHISON R, CASTO B, HAMMON W . ADENOVIRUS-ASSOCIATED DEFECTIVE VIRUS PARTICLES. Science. 1965; 149(3685):754-6. DOI: 10.1126/science.149.3685.754. View

11.

Strebhardt K, Ullrich A . Targeting polo-like kinase 1 for cancer therapy. Nat Rev Cancer. 2006; 6(4):321-30. DOI: 10.1038/nrc1841. View

12.

Zhang H, Zhang Y, Yin H . Genome Editing with mRNA Encoding ZFN, TALEN, and Cas9. Mol Ther. 2019; 27(4):735-746. PMC: 6453514. DOI: 10.1016/j.ymthe.2019.01.014. View

13.

Bolhassani A . Improvements in chemical carriers of proteins and peptides. Cell Biol Int. 2019; 43(4):437-452. DOI: 10.1002/cbin.11108. View

14.

Ananthakrishnan A, Gogineni V, Saeian K . Epidemiology of primary and secondary liver cancers. Semin Intervent Radiol. 2011; 23(1):47-63. PMC: 3036307. DOI: 10.1055/s-2006-939841. View

15.

Rao C, Asch A, Yamada H . Frequently mutated genes/pathways and genomic instability as prevention targets in liver cancer. Carcinogenesis. 2016; 38(1):2-11. PMC: 5219050. DOI: 10.1093/carcin/bgw118. View

16.

Shen A, Liu S, Yu W, Deng H, Li Q . p53 gene therapy-based transarterial chemoembolization for unresectable hepatocellular carcinoma: A prospective cohort study. J Gastroenterol Hepatol. 2015; 30(11):1651-6. DOI: 10.1111/jgh.13009. View

17.

Chen Y, E C, Gong Z, Liu S, Wang Z, Yang Y . Chimeric antigen receptor-engineered T-cell therapy for liver cancer. Hepatobiliary Pancreat Dis Int. 2018; 17(4):301-309. DOI: 10.1016/j.hbpd.2018.05.005. View

18.

Doss W, Shiha G, Hassany M, Soliman R, Fouad R, Khairy M . Sofosbuvir plus ribavirin for treating Egyptian patients with hepatitis C genotype 4. J Hepatol. 2015; 63(3):581-5. DOI: 10.1016/j.jhep.2015.04.023. View

19.

Berasain C, Avila M . The EGFR signalling system in the liver: from hepatoprotection to hepatocarcinogenesis. J Gastroenterol. 2013; 49(1):9-23. DOI: 10.1007/s00535-013-0907-x. View

20.

Bernstein E, Caudy A, Hammond S, Hannon G . Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature. 2001; 409(6818):363-6. DOI: 10.1038/35053110. View